Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
776.50    -8.00 (-1.02%)
Bid:
776.00
Ask:
777.00
Spread: 1.00 (0.129%)
Market Cap: £2.61b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

LTIP 2021 – EPS Performance Condition

9 Aug 2021 11:13

RNS Number : 0135I
Drax Group PLC
09 August 2021
 

9 August 2021

Drax Group plc

("Drax" or the "Company"; Symbol: DRX)

 

LTIP 2021 - EPS Performance Condition

 

In the Annual Report and Financial Statements of Drax Group plc for the financial year ended 31 December 2020, ('the Annual Report'), the Company explained that the Cumulative Adjusted Earnings Per Share target ('EPS'), which is one of the two performance conditions to determine vesting in respect of the grants made under the Long Term Incentive Plan ('LTIP'), would be finalised and subsequently announced via RNS after completion of the proposed acquisition of Pinnacle Renewable Energy Inc. ('Pinnacle'). Targets have been set which took account of the Company's budget approved in January, prevailing market expectations and performance of sector peers at that point in time, however finalisation was delayed in order that the targets could reflect the impact of the proposed acquisition of Pinnacle.

Subsequent to the completion of the Pinnacle acquisition in April 2021, a fair value assessment of the acquired assets has been undertaken, details of which were included in the Company's Half Year Report, issued on Thursday 29 July.

Following a meeting of the Remuneration Committee in July 2021 and the announcement of the Company's Half Year results, the proposed EPS target for the 2021 Grants has now been finalised, taking account of Pinnacle.

The vesting of awards granted in 2021 ('the 2021 Grants') shall be subject to satisfying two performance conditions over the financial years 2021, 2022 and 2023. 50% of the 2021 Grants will be measured based on Total Shareholder Return relative to the FTSE 350, and the remaining 50% will be measured based on EPS. This is in line with the current Remuneration Policy for the Company.

The targets for the EPS performance condition will be as set forth below. The threshold level, based on general practice, is set at 90% of the target level. Vesting between the threshold and maximum will be on a straight-line basis.

BASIS OF VESTING

Performance

Level of Cumulative

Adjusted EPS

Percentage of Award Vesting(of EPS performance condition)

Below threshold

<104.9p

0%

Threshold

104.9p

25%

Maximum

128.2p

100%

The EPS target is 'Adjusted EPS', derived from Adjusted Results as reported in the Company's audited financial statements. Instances where such adjustments might apply include acquisition and restructuring costs, asset obsolescence charges, costs on debt restructuring, costs and credits arising from major transactions and certain remeasurements on derivative contracts. For more information on Adjusted Results applicable for 2020, see note 2.7 of the Annual Report.

There may arise circumstances during the performance period where adjustment or discretion is applied by the Remuneration Committee by reference to exceptional items and the Remuneration Policy. The application of such adjustments would be considered during and upon completion of the performance cycle.

In making their assessment, the Remuneration Committee will take into account appropriate advice (for example from the Company's independent auditors and the Remuneration Committee advisers) and also give due consideration to the shareholder experience and that of wider stakeholders. The Remuneration Committee would also take into account exceptional and unforeseen circumstances in assessing the appropriate level of vesting judged against the performance of the Company and management at the end of the performance period.

With regard to the relative Total Shareholder Return measure, 25% of the Award will vest for median performance rising on a straight line basis to 100% vesting for upper quartile performance.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKARRAUUWRAR
Date   Source Headline
5th Jun 202610:21 amRNSHolding(s) in Company
1st Jun 202611:02 amRNSIssue of Shares
1st Jun 202610:28 amRNSTotal Voting Rights
1st Jun 20267:47 amRNSDisclosure Table
1st Jun 20267:00 amRNSOffer for Bluefield Solar Income Fund Limited
29th May 20267:00 amRNSCommissioning of First OCGT Plant
27th May 20267:00 amRNSChief Financial Officer
26th May 20268:45 amRNSApplication for block admission to trading
8th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 202610:15 amRNSTotal Voting Rights and Issue of Shares
30th Apr 202612:53 pmRNSResult of AGM
30th Apr 20267:00 amRNSTrading Update
15th Apr 20268:45 amRNSApplication for block admission to trading
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:46 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202612:09 pmRNSIssue of Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20269:48 amRNSNotice of AGM and Annual Report and Accounts
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 202610:35 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20264:43 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSCapacity Market Agreements
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSAppointment of Interim CFO
5th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.